US equities |
MU $1,029.00 ▼-0.66% NVDA $229.28 ▼-0.52% SPCX $162.57 ▲+1.25% TSLA $382.70 ▲+2.05% AAPL $336.64 ▼-1.11% MSFT $535.07 ▲+2.38% AMZN $262.43 ▲+3.29% META $718.67 ▼-0.31%
FinancialContent

Articles published by DexCom, Inc.

< Previous 1 2 3 4 5 Next >
News headline image
Dexcom Schedules Third Quarter 2026 Earnings Release and Conference Call for October 29, 2026 at 4:30 p.m. Eastern Time
From DexCom, Inc.
Via Business Wire
Tickers DXCM
News headline image
Dexcom U Enters Season 5 With a Record Roster and Evidence That Diabetes Stigma Among Young Athletes Is Fading
From DexCom, Inc.
Via Business Wire
Tickers DXCM
News headline image
Dexcom Publishes New Report During EASD 2026 on Type 2 Diabetes Revealing Critical Opportunity for Global Diabetes Care
From DexCom, Inc.
Via Business Wire
Tickers DXCM
News headline image
Dexcom Promotes Jereme Sylvain to Chief Operating Officer
From DexCom, Inc.
Via Business Wire
Tickers DXCM
News headline image
Dexcom Appoints Glenn Boehnlein to Board of Directors
From DexCom, Inc.
Via Business Wire
Tickers DXCM
News headline image
Dexcom Announces Upcoming Conference Presentation
From DexCom, Inc.
Via Business Wire
Tickers DXCM
News headline image
Dexcom Reports Second Quarter 2026 Financial Results
From DexCom, Inc.
Via Business Wire
Tickers DXCM
News headline image
Dexcom Announced as First Participant Selected for FDA's TEMPO Digital Health Devices Pilot Program
From DexCom, Inc.
Via Business Wire
Tickers DXCM
News headline image
Dexcom Schedules Second Quarter 2026 Earnings Release and Conference Call for July 30, 2026 at 4:30 p.m. Eastern Time
From DexCom, Inc.
Via Business Wire
Tickers DXCM
News headline image
Dexcom Further Advances Vision of Glucose Biosensing for All
From DexCom, Inc.
Via Business Wire
Tickers DXCM
News headline image
Dexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits for People with Type 2 Diabetes Not Using Insulin
From DexCom, Inc.
Via Business Wire
Tickers DXCM
News headline image
Dexcom Uncovers Theft of Scrapped Product, Notifies Potentially Impacted Users
From DexCom, Inc.
Via Business Wire
Tickers DXCM
News headline image
Redefining CGM for People With Type 2 Diabetes: Dexcom Announces Dexcom Flex in Germany
From DexCom, Inc.
Via Business Wire
Tickers DXCM
News headline image
Dexcom Announces Governance Enhancements Ahead of 2026 Investor Day
From DexCom, Inc.
Via Business Wire
Tickers DXCM
News headline image
Dexcom to Host Investor Day on May 14, 2026
From DexCom, Inc.
Via Business Wire
Tickers DXCM
News headline image
Dexcom Reports First Quarter 2026 Financial Results
From DexCom, Inc.
Via Business Wire
Tickers DXCM
News headline image
Dexcom Schedules First Quarter 2026 Earnings Release and Conference Call for April 30, 2026 at 4:30 p.m. Eastern Time
From DexCom, Inc.
Via Business Wire
Tickers DXCM
News headline image
Dexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes and Product Roadmap at ATTD 2026
From DexCom, Inc.
Via Business Wire
Tickers DXCM
News headline image
Dexcom Appoints Rick Osterloh to Board of Directors
From DexCom, Inc.
Via Business Wire
Tickers DXCM
News headline image
Dexcom Announces Upcoming Conference Presentation
From DexCom, Inc.
Via Business Wire
Tickers DXCM
News headline image
Dexcom Reports Fourth Quarter and Fiscal Year 2025 Financial Results
From DexCom, Inc.
Via Business Wire
Tickers DXCM
News headline image
Stelo Adds Enhanced Smart Meal Logging Features as Dexcom Continues to Transform Personal Glucose Management
From Dexcom, Inc.
Via Business Wire
Tickers DXCM
News headline image
Dexcom Schedules Fourth Quarter and Fiscal Year 2025 Earnings Release and Conference Call for February 12, 2026 at 4:30 p.m. Eastern Time.
From DexCom, Inc.
Via Business Wire
Tickers DXCM
News headline image
Dexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook
From DexCom, Inc.
Via Business Wire
Tickers DXCM
News headline image
Dexcom Enters Next Era of Continued Innovation With Jake Leach as President and Chief Executive Officer
From DexCom, Inc.
Via Business Wire
Tickers DXCM
News headline image
Dexcom G7 15 Day Continuous Glucose Monitoring System to Launch on Dec. 1 in the United States
From DexCom, Inc.
Via Business Wire
Tickers DXCM
News headline image
Dexcom Smart Basal Receives FDA Clearance Becoming the First and Only CGM-integrated Basal Insulin Dosing Optimizer for Type 2 Diabetes
From DexCom, Inc.
Via Business Wire
Tickers DXCM
News headline image
Dexcom Reveals Global Diabetes Advocates: New Voices for Diabetes Awareness This World Diabetes Day
From DexCom, Inc.
Via Business Wire
Tickers DXCM
News headline image
Dexcom Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Guidance
From DexCom, Inc.
Via Business Wire
Tickers DXCM
News headline image
Dexcom Appoints Euan Ashley to Board of Directors
From DexCom, Inc.
Via Business Wire
Tickers DXCM
< Previous 1 2 3 4 5 Next >